Ocular findings in cats with feline infectious peritonitis treated with GS-441524: a preliminary prospective study of 118 cases

GS-441524治疗猫传染性腹膜炎的猫的眼部表现:一项包含118例病例的初步前瞻性研究

阅读:1

Abstract

ObjectivesThis study aims to characterise the presence and nature of ocular findings in cats diagnosed with feline infectious peritonitis (FIP) and to evaluate the effects of antiviral treatment with GS-441524 on ocular manifestations.MethodsStudy participants were prospectively recruited over a 1-year period by the FIP study team at the Vetsuisse Faculty, University of Zurich. A total of 118 cats diagnosed with FIP underwent a comprehensive standardised semi-quantitative ophthalmic examination. Cats with ophthalmic abnormalities at the baseline examination received a follow-up examination on days 7 and 42, after commencement of the oral antiviral therapy, GS-441524. Changes throughout the treatment period were recorded and reviewed.ResultsAt the baseline examination, 48/118 (40.1%) cats had ocular abnormalities, with the most common associated findings being anterior uveitis, keratic precipitates and chorioretinitis. Throughout the course of treatment with GS-441524, significant improvements were observed in all ocular segments, with rapid improvement noted during the first 7 days of treatment in most cases. Residual chorioretinal lesions and vitreal cells persisted in a minority of cases.Conclusions and relevanceThis study suggests that ocular abnormalities in cats with FIP are more common than previously reported. Potentially vision-threatening posterior segment changes occurred frequently, and treatment with oral GS-441524 led to rapid improvement in most ocular lesions, particularly uveitis and chorioretinitis. These findings support the inclusion of ophthalmic examination as part of the clinical evaluation of cats with suspected or diagnosed FIP.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。